Drawing for AY

USPTO serial 97537565

AY

Reviewed by CopyMark Law Group

Reg. 7431424Status 700Registered
Filing date
Status date
Registration date
Jul 2, 2024
Examiner
WU, KRISTEN ZAHNOW
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CLAUDIA W. STANGLE

CLAUDIA W. STANGLE LEYDIG, VOIT & MAYER, LTD.TWO PRUDENTIAL PLAZA, 180 N. STETSON AVESUITE 4900CHICAGO, IL 60601

Goods and services

ClassDescriptionStatusFirst use
005Chemical products for medical use, namely reagents; Biomedical preparations for medical use, namely, preparations for the treatment of cancer, auto-immune diseases, infectious diseases; Cell biological preparations for medical use, namely, preparations for the treatment of cancer, auto-immune diseases, infectious diseases; Diagnostic preparations for medical purposes; Detergents for medical purposes; Chemical reagents for conducting tests for medical and veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissue for use in disease detection, namely cancer, auto-immune diseases, infectious diseasesACTIVE—
0073D printers and industrial printing machines and replacement parts thereof, including print heads; 3D printers for organic substances; 3D printers in the nature of piezo-driven and laser-driven single cell printers and replacement parts thereof, including print headsACTIVE—
009Imaging devices for use in scientific research, namely, scanners and microscopes for capturing images and measuring optical signals relating to the optical analysis of cells; Polynucleotide microarrays; Laboratory apparatus, namely, lab-on-a-chip systems comprised of glass chips for use in chemical and biological analysis, electrodes for laboratory research, sensor chips for scientific use, microchips; Laboratory apparatus and computer systems for use in the analysis of live cells; Laboratory devices and instruments, namely, glass chips for use in chemical and biological analysis for use with lab-on-a-chip systems; Laboratory apparatus for use in research, science and industry, namely, microscopes, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, and cell culturing stations; Laboratory instruments for use in the fields of scientific research, scientific education and industry, namely, microscopes, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, and cell culturing stations; Laboratory apparatus and instruments, namely, microscopes, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, and cell culturing stations; Laboratory devices, apparatus and equipment, namely, microscopes, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, and cell culturing stations for high definition and highly sensitive analyses; Laboratory devices, scientific apparatus and instruments used for microscopy, namely, fluorescence microscopes, bright-field microscopes, dark-field microscopes, phase-contract microscopes, confocal microscopes; Laboratory devices, scientific apparatus and instruments used for measuring pressure, namely pressure gauges; Laboratory devices, scientific apparatus and instruments, namely, pipettes used for aspiration of cells; Laboratory devices, scientific apparatus and instruments for use with microarrays and microfluid chips for the analysis, selection and manipulation of biological cells and biological materials, namely, microscopes, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, and cell culturing stations; Laboratory devices, scientific apparatus and instruments used for biological, genetic, chemical, medical and scientific research and analysis and pharmaceutical development, namely, microplate readers, apparatus for aspirating cell culture samples, cell culture mediums, cells, polymers and glass beads for scientific research purposes, cell culturing stations, and microscopes; Microscopes; Apparatus and instruments for microscopy, namely, microscope objectives, lenses for microscopes, reflectors for microscopes, filters for microscopes; Electric sensors; Laboratory equipment, namely, microarray scanners and microarray readers; polynucleotide and protein microarrays for measuring characteristics of cellsACTIVE—
010Medical diagnostic and therapeutic devices, namely, devices for measuring cell characteristics and for characterization of cells in immune therapy and cancer therapy; Sensors for medical use to gather animal biometric dataACTIVE—
042Biological cells analysis services in the fields of cell biology, life sciences, genetic science, namely cell line development, cell therapy, monoclonal antibodies, drug development, synthetic biology; Counselling in the field of life sciences and biotechnology; Counselling, in the field of biotechnology, namely, providing scientific assessment of biological cells; Providing of non-medical diagnostic services for others in the field of lab-on-a-chip devices and equipment for preparing and analyzing lab-on-a-chip devices relating to the study of cell characteristics and biomedical research relating thereto; Research relating to biotechnology; Electronic storage of data and compiling data in databases for scientific research purposes in the field of biological sciences; Conducting laboratory testing and laboratory analysis using biological cells, biological materials and/or chemicals in the field of cell line development, cell therapy, monoclonal antibodies, drug development, synthetic biology; Design and development of medical diagnostic apparatus; Product design and development in the field of medical technology; Development and maintenance of databases in the field of biological sciences, life sciences and medical technology for others; Research and development in the fields of biology, biotechnology, life sciences, genetic science, chemistry, medicine, and science; Research and development in the field of cells cultivated within bioreactors; Pharmaceutical products development; Scientific laboratory services relating to isolating and culturing live cells; Scientific laboratory services relating to using natural cells and artificially created cellsACTIVE—
044Medical diagnostic testing, monitoring and reporting services for others relating to the study of cell characteristicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 8, 2024EXPTEXPARTE APPEAL TERMINATED—
Mar 8, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 8, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 8, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 8, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 9, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 24, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 24, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 24, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 30, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Mar 30, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 30, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Mar 6, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 1, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 30, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 30, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 30, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2022DOCKASSIGNED TO EXAMINER—
Sep 7, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 30, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 9, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance